SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 55.71 |
| Enterprise Value ($M) | 26.76 |
| Book Value ($M) | 11.54 |
| Book Value / Share | 0.48 |
| Price / Book | 2.12 |
| NCAV ($M) | -102.23 |
| NCAV / Share | -1.85 |
| Price / NCAV | -0.54 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.51 |
| Return on Assets (ROA) | -0.36 |
| Return on Equity (ROE) | -1.04 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.61 |
| Current Ratio | 2.19 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 38.95 |
| Assets | 152.73 |
| Liabilities | 141.18 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Fmr Llc | 10.68 | 11.39 | |
| 13G/A | HarbourVest Partners L.P. | 6.40 | 32.68 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 440,229 | 1,348,919 | 32.64 | |
| 101,340 | 267,681 | 37.86 | |
| 61,717 | 209,893 | 29.40 | |
| 100,600 | 283,874 | 35.44 | |
| 72,143 | 199,051 | 36.24 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| NXTC – NextCure, Inc. | OGI – Organigram Holdings Inc. |
| OLMA – Olema Pharmaceuticals, Inc. | OPK – OPKO Health, Inc. |
| OPTN – OptiNose, Inc. |
Financial data and stock pages provided by
Fintel.io